Pharmafile Logo

York Health Economics Consortium offers a new health utilities training course

July 4, 2018 – Pharmaceutical –

Cost-utility analysis is a requirement for NICE health technology appraisals and is being increasingly used in other contexts and countries. Health utilities, a crucial component of cost-utility analysis, capture the relative change in health-related quality of life resulting from a treatment. As such, health utility can be a key driver of the cost-effectiveness ratio. Obtaining health utility values that are suitable for your economic evaluation, however, may not always be straight forward.

Our new one-day Health Utilities for Economic Models course, running on 4th July 2018, complements our Early Economic Modelling course. It outlines different approaches to obtaining utility values and provides an overview of the associated strengths and limitations across different contexts. Examples of the different approaches used in real-world NICE health technology assessments will be shared, with comments from evidence review groups, and we will take a look at the limitations of utilities and discuss how alternative approaches might be used in the future.

For those also interested in patient reported outcome measures more generally, York Health Economics Consortium is also running the Introduction to Patient Reported Outcomes Measures training course on the 7th March this year.

YHEC
andria.hanbury@york.ac.uk
Address: YHEC, Enterprise House, Innovation Way, University of York, York, YO10 5NQ, United Kingdom